January 23, 2019
Rose
But Johnson & Johnson said it expects its sales growth to slow in 2019. Meanwhile, the company has agreed to pay $120 million to resolve claims over deceptive marketing.
from Kaiser Health News http://bit.ly/2S1Gczr
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment